Value-based care and medical technology

Assessing the value of medtech products and offerings

The health care ecosystem is in the midst of a shift from volume-based, fee-for-service (FFS) systems to value-based care (VBC) models. AdvaMed launched a Strategic Value Initiative with Deloitte Consulting LLP to develop principles and an approach for assessing the value of medical technologies.